Korea FDA Issues Approval To Chong Kun Dang For Future Sales Of Generic Tamiflu
This article was originally published in PharmAsia News
Executive Summary
SEOUL - The Korea Food & Drug Administration granted approval to local South Korean Chong Kun Dang Pharmaceutical to sell its generic version of Roche's Tamiflu (oseltamivir) at some point in the future